Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

Howard, JF (author)

Bril, V (author)

Burns, TM (author)

show more...

Mantegazza, R (author)

Bilinska, M (author)

Szczudlik, A (author)

Beydoun, S (author)

Garrido, FJRD (author)

Piehl, F (author)

Karolinska Institutet

Rottoli, M (author)

Van Damme, P (author)

Vu, T (author)

Evoli, A (author)

Freimer, M (author)

Mozaffar, T (author)

Ward, ES (author)

Dreier, T (author)

Ulrichts, P (author)

Verschueren, K (author)

Guglietta, A (author)

de Haard, H (author)

Leupin, N (author)

Verschuuren, JJGM (author)

Claeys, K (author)

Diez-Tejedor, E (author)

Mathew, V (author)

Sgarzi, M (author)

Harvey, BL (author)

Farias, J (author)

Frangiomore, R (author)

Heintzman, S (author)

de Meel, R (author)

Chopra, M (author)

Alboini, PE (author)

Hietala, A (author)

Karolinska Institutet

Genge, A (author)

show less...

 (creator_code:org_t)

2019

2019

English.

In: Neurology. - 1526-632X. ; 92:23, s. E2661-E2673

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)